Description

Dipeptidylpeptidase Iv Inhibitor Ii is a potent and selective small-molecule inhibitor of the DPP-4 enzyme, a key target in metabolic and immunological research. This high-purity compound is essential for advancing studies into type 2 diabetes, autoimmune disorders, and other therapeutic areas where DPP-4 activity plays a critical role. It is primarily utilized by pharmaceutical R&D laboratories, academic research institutions, and biotechnology companies engaged in drug discovery and biochemical pathway analysis.

Application

• Drug Discovery & Pharmaceutical Research: Serves as a critical reference standard and active pharmacological tool for developing novel anti-diabetic and immunomodulatory therapies.
• Biochemical & Enzymology Studies: Used to specifically inhibit DPP-4 enzyme activity in in vitro assays to study its function, kinetics, and role in peptide hormone regulation.
• Metabolic Disease Research: A key reagent in preclinical research models for investigating the pathophysiology and potential treatment of type 2 diabetes and obesity.
• Immunology and Inflammation Research: Employed to explore the role of DPP-4 (CD26) in T-cell activation and immune response modulation for autoimmune and inflammatory conditions.
• Academic & Contract Research: Provides a reliable, high-quality compound for basic scientific research and outsourced preclinical testing services.
• High-Throughput Screening (HTS): Used as a control compound in screening campaigns to identify new DPP-4 inhibitor leads from compound libraries.

Basic Information

Product Name	Dipeptidylpeptidase Iv Inhibitor Ii
CAS No.	1258008-19-3
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	DPP-4 Inhibitor II; DPP-IV Inhibitor II; Sitagliptin analogue; DPP4 Inhibitor; Dipeptidyl Peptidase 4 Inhibitor II; 2-[[6-Chloro-3-methyl-2,4-dioxo-1-(2,2,2-trifluoroethyl)-3,4-dihydro-1H-pyrrolo[3,2-d]pyrimidin-5-yl]methyl]-4-fluorobenzonitrile; (Alternative research codes may apply)
EINECS	Contact for details

Quality Control

Our Dipeptidylpeptidase Iv Inhibitor Ii is manufactured under strict quality systems to ensure batch-to-batch consistency and reliability for sensitive research applications. Each lot undergoes comprehensive analytical characterization, including purity verification by HPLC and structural confirmation. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting the specific results for your quality assurance and regulatory compliance needs.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the certificate of analysis. Keep the container in a dry, well-ventilated place. Handle and store in accordance with good laboratory practices.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.